Abstract: Embodiments of the presently disclosed subject matter relate to systems, methods, and devices for asset control and management systems. According to some embodiments, an asset control and management system can comprise a network comprising a network memory; and a host computer connected to the network, the host computer comprising a non-transitory computer-readable medium comprising instructions executable by a processor to: operate a management program configured to access a checklist; determine a difference between an asset status and the checklist; receive from a network database associated with the network memory an executable program associated with a response; and implement the response to change the asset to match the checklist.

Abstract: This invention relates to novel compounds and pharmaceutical compositions comprising. Compounds of the invention useful as modulators of Rho-associated protein kinase (ROCK), for example ROCK1 and/or ROCK2 inhibitors. Methods of treatment employing the compounds are also contemplated by the present invention. The compounds of the invention are useful in treating ROCK mediated diseases.

Abstract: This invention relates to novel compounds and pharmaceutical compositions comprising. Compounds of the invention useful as modulators of Rho-associated protein kinase (ROCK), for example ROCK1 and/or ROCK2 inhibitors. Methods of treatment employing the compounds are also contemplated by the present invention. The compounds of the invention are useful in treating ROCK mediated diseases.

Abstract: This invention relates to novel compounds and pharmaceutical compositions comprising. Compounds of the invention useful as modulators of Rho-associated protein kinase (ROCK), for example ROCK1 and/or ROCK2 inhibitors. Methods of treatment employing the compounds are also contemplated by the present invention. The compounds of the invention are useful in treating ROCK mediated diseases.

Abstract: This invention relates to novel compounds and pharmaceutical compositions comprising the same. Compounds of the invention useful as modulators of Rho-associated protein kinase (ROCK), for example ROCK1 and/or ROCK2 inhibitors. Methods of treatment employing the compounds are also contemplated by the present invention. The compounds of the invention are useful in treating ROCK mediated diseases.

Abstract: This invention relates to novel compounds and pharmaceutical compositions comprising the same. Compounds of the invention useful as modulators of Rho-associated protein kinase (ROCK), for example ROCK1 and/or ROCK2 inhibitors. Methods of treatment employing the compounds are also contemplated by the present invention. The compounds of the invention are useful in treating ROCK mediated diseases.

Abstract: The invention relates to a dental device and an edible pet chew. The dental device comprises a dental protection composition containing at least one barrier material, at least one activated phosphatidylcholine, and, optionally, mineral oil. The edible pet chew comprises a dental protection composition, gelatin, and, optionally, one or more humectants, one or more preservatives, one or more structure-providing components, and one or more flavoring ingredients, wherein the dental protection composition contains at least one barrier material, at least one phosphatidylcholine, and, optionally, mineral oil.

Abstract: The invention relates to a dental device and an edible pet chew. The dental device comprises a dental protection composition containing at least one barrier material, at least one activated phosphatidylcholine, and, optionally, mineral oil. The edible pet chew comprises a dental protection composition, gelatin, and, optionally, one or more humectants, one or more preservatives, one or more structure-providing components, and one or more flavoring ingredients, wherein the dental protection composition contains at least one barrier material, at least one phosphatidylcholine, and, optionally, mineral oil.

Abstract: The present invention relates to compounds of formula (I) its salts, isomers or prodrugs thereof useful in the treatment of viral infections, in particular respiratory syncytial virus (RSV) infections. The present invention also relates to processes for preparing the compounds and intermediates used in their preparation.

Abstract: The present invention relates to compounds of formula (I) its salts, isomers or prodrugs thereof useful in the treatment of viral infections, in particular respiratory syncytial virus (RSV) infections. The present invention also relates to processes for preparing the compounds and intermediates used in their preparation.

Abstract: The present invention relates to compounds of formula (I) its salts, isomers or prodrugs thereof useful in the treatment of viral infections, in particular respiratory syncytial virus (RSV) infections. The present invention also relates to processes for preparing the compounds and intermediates used in their preparation.

Abstract: The present invention relates to compounds of formula (I) its salts, isomers or prodrugs thereof useful in the treatment of viral infections, in particular respiratory syncytial virus (RSV) infections. The present invention also relates to processes for preparing the compounds and intermediates used in their preparation.

Abstract: The present invention relates to compounds of formula (I) its salts, isomers or prodrugs thereof useful in the treatment of viral infections, in particular respiratory syncytial virus (RSV) infections. The present invention also relates to processes for preparing the compounds and intermediates used in their preparation.

Abstract: The present invention relates to compounds of formula (I) its salts, isomers or prodrugs thereof useful in the treatment of viral infections, in particular respiratory syncytial virus (RSV) infections. The present invention also relates to processes for preparing the compounds and intermediates used in their preparation.

Abstract: The present invention relates to active delivery system formulations, and methods of making and using the same. Said formulations, when applied to a substrate surface, form a protective coating on the surface and permit constituent active agents to act on the surface and in the surrounding medium.

Abstract: Disclosed are novel compounds according to general formula (I), which have shown OT agonist activity.

Abstract: A method of setting-up machine vision equipment is disclosed. The equipment includes a camera defining a field of view, processing means for determining physical properties of a test object, and first supporting means for supporting a test object at a predetermined distance from the camera within the field of view. The method is characterised by providing second supporting means for supporting a reference object, placing a reference object having at least one known dimension on the second supporting means, moving one or more of the cameras, the first supporting means and the second supporting means to bring the reference object within the field of view at the predetermined distance from the camera, imaging the reference object to obtain an image, and processing the image to determine the optimum configuration of the imaging means, and adjusting the imaging means configuration to the optimum configuration.

Abstract: This invention provides novel compounds according to general formula (1) wherein A is a bicyclic or tricyclic azepine derivative, V1 and V2 are both H, OMe or F, or one of V1 and V2 is Br, Cl, F, OH, OMe, OBn, OPh, O-acyl, N3, NH2, NHBn or NH-acyl and the other is H, or V1 and V2 together are ?O, —O(CH2)pO— or —S(CH2)pS—; W1 is either O or S; X1 and X2 are both H, or together are ?O or ?S; Y is OR5 or NR6R7; R1, R2, R3 and R4 are independently selected from H, lower alkyl, lower alkyloxy, F, Cl and Br; R5 is selected from H and lower alkyl; R6 and R7 are independently selected from H and lower alkyl, or together are —(CH2)n; n=3, 4, 5, 6; and p is 2 or 3. The compounds are agonists at the vasopressin V2 receptor and are useful as antidiuretics and procoagulants. The invention further comprises pharmaceutical compositions incorporating these vasopressin agonists, which compositions are particularly useful in the treatment of central diabetes insipidus, nocturnal enuresis and nocturia.

Abstract: A method of determining one or more physical properties of a rolled smoking article is disclosed, the method comprising disposing a rolled smoking article within a field of view, illuminating the field of view, imaging the rolled smoking article to form an image, and analysing the image to determine one or more physical properties of the rolled smoking article. Preferably the image is a digital image, which may be electronically processed to determine the physical properties. The physical properties may include the length of the rolled smoking article, or its mean diameter, ovality, circumference, roundness or shape. Also disclosed is an apparatus for performing such method comprising imaging means defining the field of view, means for positioning a smoking article in the field of view, illuminating means for illuminating the field of view, and processing means for processing the image to determine one more physical properties.

Abstract: A door assembly includes an inner panel, an outer panel fixedly attached to the inner panel, and a load transfer element disposed within an interstitial space formed between the inner and outer panels. The load transfer element includes a main body defining a longitudinal axis extending from the inner panel to the outer panel and first and second reaction surfaces disposed on the main body. The first reaction surface is formed proximate the inner panel while the second reaction surface is formed generally opposite the first reaction surface and proximate the outer panel. The second reaction surface is operable to receive a load from the outer panel and to transmit the load through the main body to the first reaction surface and the door inner panel. The load transfer element is further configured to activate an air bag sensor when the load exceeds a predetermined magnitude.